Growth Metrics

Cme (CME) Liabilities and Shareholders Equity (2016 - 2026)

Cme has reported Liabilities and Shareholders Equity over the past 18 years, most recently at $202.0 billion for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 27.98% to $202.0 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $767.5 billion through Mar 2026, up 37.92% year-over-year, with the annual reading at $198.4 billion for FY2025, 44.36% up from the prior year.
  • Liabilities and Shareholders Equity was $202.0 billion for Q1 2026 at Cme, up from $198.4 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $205.9 billion in Q1 2022 and troughed at $123.4 billion in Q2 2024.
  • The 5-year median for Liabilities and Shareholders Equity is $166.0 billion (2023), against an average of $162.6 billion.
  • Biggest five-year swings in Liabilities and Shareholders Equity: decreased 29.61% in 2023 and later soared 45.82% in 2025.
  • Tracing CME's Liabilities and Shareholders Equity over 5 years: stood at $174.2 billion in 2022, then decreased by 25.53% to $129.7 billion in 2023, then increased by 5.97% to $137.4 billion in 2024, then surged by 44.36% to $198.4 billion in 2025, then increased by 1.8% to $202.0 billion in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $202.0 billion, $198.4 billion, and $187.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.